#EBW25 Editorial: empowering biobanks with smart solutions from Twin Helix
This article has 320 words and is a 2-minute read.
The Europe Biobank Week Congress highlights new developments and addresses key topics in the global biobanking and biomolecular resources field. It brings together professionals, patients, and government officials to share insights and foster collaboration. Over the course of four days, participants can attend inspiring keynote speeches, join in discussions, network with others, and explore exhibits showcasing cutting-edge technologies and innovations.
We have spoken with all of our sponsors for 2025 to understand why they value being part of the most important in-person event of the year for the global biobanking community. Here’s what Twin Helix had to say.
Company description
Since 2007, we have been a trusted partner in the Life Sciences sector, providing cutting-edge solutions for biobanking and sample management. Our proprietary software, EasyTrack2D©, is specifically designed to ensure the secure and efficient storage of chemical and biological samples, supporting the needs of translational and personalised medicine. In addition to software solutions, we offer a range of specialised products for biorepositories, molecular and cellular biology research, and innovative applications such as cellular reprogramming and 3D in vitro cultures. By combining our expertise in distribution with in-house development, we provide tailored solutions that optimise biobank workflows and drive progress in biomedical research.
Why does it matter to be at EBW25?
This congress allows us to engage with biobanks managers, gain valuable insights into their challenges, and strengthen our relationships with the European community. We are committed to supporting the development of cutting-edge biobank solutions, and EBW25 is the perfect platform to reinforce this vision
What new innovation are you bringing or what are you most looking forward to?
Our EasyTrack2D software now includes four new modules specifically designed to help biobanks achieve ISO 20387 compliance, covering critical areas such as informed consent management and non-conformity tracking. To further support data sharing and collaboration, we have also introduced a dedicated module for BBMRI.it, enabling standardised data export and interoperability across biobanks.